Role of P-Glycoprotein in Regulating Cilnidipine Distribution to Intact and Ischemic Brain

  • YANO Kentaro
    Faculty of Pharmacy, Takasaki University of Health and Welfare
  • TAKIMOTO Shinobu
    Faculty of Pharmacy, Takasaki University of Health and Welfare
  • MOTEGI Toshimitsu
    Faculty of Pharmacy, Takasaki University of Health and Welfare
  • TOMONO Takumi
    Faculty of Pharmacy, Takasaki University of Health and Welfare
  • HAGIWARA Mihoko
    Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Toho University
  • IDOTA Yoko
    Faculty of Pharmacy, Takasaki University of Health and Welfare
  • MORIMOTO Kaori
    Department of Drug Absorption and Pharmacokinetics, Tohoku Pharmaceutical University
  • TAKAHARA Akira
    Department of Pharmacology and Therapeutics, Faculty of Pharmaceutical Sciences, Toho University
  • OGIHARA Takuo
    Faculty of Pharmacy, Takasaki University of Health and Welfare

この論文をさがす

抄録

Cilnidipine is reported to show antihypertensive and neuroprotective actions in a rat brain ischemia model, but is barely distributed to normal brain, suggesting that its uptake into normal brain is inhibited by efflux transporter(s), such as P-glycoprotein (P-gp). Here, we investigated whether P-gp regulates the brain distribution of cilnidipine. Intracellular accumulation of cilnidipine was decreased in P-gp-overexpressing porcine kidney epithelial cells (LLC-GA5-COL150 cells) compared with control LLC-PK1 cells and the decrease was markedly inhibited by verapamil, a P-gp inhibitor. Further, cilnidipine concentration in the brain of P-gp knockout mice was significantly increased after cilnidipine administration, compared with that in wild-type mice. Moreover, when cilnidipine was administered to male spontaneously hypertensive rats (SHR) with tandem occlusion of the distal middle cerebral and ipsilateral common carotid artery, its concentration in the ischemic hemisphere was 1.6-fold higher than that in the contralateral hemisphere. This result was supported by visualization of cilnidipine distribution using matrix-assisted laser desorption/ionization-time of flight/mass spectrometry (MALDI-TOF/MS) imaging. Our results indicated that cilnidipine is normally excluded from the brain by P-gp-mediated efflux transport, but P-gp function is impaired in ischemic brain and consequently cilnidipine is distributed to the ischemic region.

収録刊行物

被引用文献 (6)*注記

もっと見る

参考文献 (23)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ